BIOCRYST PHARMACEUTICALS INC

Ticker: BCRX CUSIP: 09058V103 Class: Common Stock

Versant Capital Management, Inc's Holding History (CIK: 0001735057)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025

Shares 154 Value ($000) $1 Avg Close $7.23 Range $6.00 - $8.17

Q3 2025

Shares 154 Value ($000) $1 Avg Close $8.33 Range $7.42 - $9.23

Q2 2025

Shares 154 Value ($000) $1 Avg Close $9.31 Range $6.02 - $11.31

Q2 2023

Shares 59 Value ($000) $0 Avg Close $8.02 Range $6.87 - $9.07

Period	Shares	Value ($000)	Average Close	Price Range
Q4 2025	154	$1	$7.23	$6.00 - $8.17
Q3 2025	154	$1	$8.33	$7.42 - $9.23
Q2 2025	154	$1	$9.31	$6.02 - $11.31
Q2 2023	59	$0	$8.02	$6.87 - $9.07